- Home
- RPRX vs ONON Comparison
RPRX vs ONON Comparison
Compare RPRX & ONON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RPRX | ONON |
|---|---|---|
| Founded | 1996 | 2010 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Shoe Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.2B | 14.8B |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | RPRX | ONON |
|---|---|---|
| Price | $39.70 | $47.98 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 20 |
| Target Price | $46.00 | ★ $62.75 |
| AVG Volume (30 Days) | 4.3M | ★ 9.9M |
| Earning Date | 11-05-2025 | 11-12-2025 |
| Dividend Yield | ★ 2.21% | N/A |
| EPS Growth | N/A | ★ 74.51 |
| EPS | ★ 1.75 | 0.84 |
| Revenue | $2,349,844,000.00 | ★ $3,607,815,596.00 |
| Revenue This Year | $37.13 | $31.86 |
| Revenue Next Year | $1.48 | $22.90 |
| P/E Ratio | ★ $22.68 | $57.01 |
| Revenue Growth | 3.70 | ★ 33.26 |
| 52 Week Low | $24.05 | $34.38 |
| 52 Week High | $41.24 | $64.05 |
Technical Indicators
Market Signals| Indicator | RPRX | ONON |
|---|---|---|
| Relative Strength Index (RSI) | 57.50 | 70.87 |
| Support Level | $39.24 | $43.17 |
| Resistance Level | $40.50 | $43.57 |
| Average True Range (ATR) | 0.91 | 1.70 |
| MACD | -0.08 | 0.77 |
| Stochastic Oscillator | 76.02 | 99.75 |
Price Performance
Historical ComparisonAbout RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About ONON On Holding AG
On Holding AG is a premium performance sports brand rooted in technology, design, and impact. Its shoes, apparel, and accessories products are designed predominantly for athletic use, casual, or leisure purposes. It does not manufacture the products or the raw materials and relies instead on third-party suppliers and contract manufacturers. Geographically, it derives a majority of its revenue from the Americas and rest from Europe, Middle East and Africa and Asia-Pacific region.